RCKT

Rocket Pharmaceu

3.78

0.04+1.07%

After Hours: 3.740 -0.04 -1.06%19:49 02/20 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.690/3.740

TODAY RANGE3.630-3.900

VOL2.48M

MARKET CAP409.08M

52 WEEK RANGE2.190-11.11

AVG VOL (3M)2.03M

% TURNOVER2.29%

TURNOVER--

P/E (TTM)-1.6819

% RANGE7.22%

EPS(TTM)-2.2474

P/E(FORWARD)-1.8439

P/B1.304

BVPS2.899

DIVIDEND--

P/S18.82

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP393.20M

SHARES OUTSTANDING108.22M

NEXT EARNINGS02/25-03/02

FREE FLOAT104.02M

LOT SIZE1

EX-DATE01/05/2018

News

Press Releases

Financial Reports

Profile

TipRanks·6h ago
Rocket Pharmaceuticals CEO Makes Notable Insider Move With Fresh Stock Sale
TipRanks·2d ago
Rocket Pharmaceuticals Insiders Quietly Unload Shares in a Wave of Executive Stock Sales
TipRanks·01/15 11:20
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN) and Rocket Pharmaceuticals (RCKT)
TipRanks·01/08 12:46
Rocket Pharmaceuticals price target lowered to $5 from $7 at Morgan Stanley
NASDAQ·01/07 15:40
Wednesday 1/7 Insider Buying Report: CASY, RCKT
Reuters·01/06 21:05
Rocket Pharmaceuticals Director Elisabeth Bjork Acquires Common Shares
Reuters·01/05 12:00
Rocket Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Dow Jones·01/02 17:06
Rocket Pharmaceuticals Seen With Continued Progress in 2026 -- Market Talk
Seeking Alpha·12/26/2025 15:23
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program
TipRanks·12/18/2025 11:50
Analysts Have Conflicting Sentiments on These Healthcare Companies: Insmed (INSM), Novan (NOVN) and Rocket Pharmaceuticals (RCKT)
TipRanks·12/12/2025 13:20
Tenaya Therapeutics price target lowered to $8 from $9 at Chardan
Reuters·11/25/2025 12:00
Rocket Pharmaceuticals CEO to Join Evercore Healthcare Conference Fireside Chat
TipRanks·11/21/2025 02:13
Rocket Pharmaceuticals CEO Makes Strategic Stock Move
Reuters·11/20/2025 21:06
Rocket Pharmaceuticals Officer Jonathan David Schwartz Reports Disposal of Common Shares
Reuters·11/20/2025 21:06
Rocket Pharmaceuticals CEO Gaurav Shah Reports Sale of Common Shares

Same Industry

Name/Symbol

Change%

Price

Rocket Pharmaceu

RCKT

+1.07%

3.78

Regeneron Pharmaceuticals

REGN

-0.23%

779.67

GridAI Tech

GRDX

-5.15%

2.58

BIONTECH

BNTX

-0.25%

110.15

United Therapeutics Corp.

UTHR

-1.48%

473.42

Vertex Pharmaceuticals Inc

VRTX

+1.63%

476.90

Siga Technologie

SIGA

-0.30%

6.75

Moderna

MRNA

+0.34%

49.87

Charles Riv Labs Intl Inc

CRL

+2.85%

168.92

Medpace Holdings

MEDP

+1.64%

453.77

Talphera Inc

TLPH

-3.87%

0.7766

ICON PLC

ICLR

+1.31%

99.70

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

-2.21%

165.62

MOLECULAR PARTNERS AG

MOLN

0.00%

5.00

Arcturus Therape

ARCT

-3.76%

7.67

Gilead Sciences Inc

GILD

+0.19%

151.40

PRA Health

PRAH

165.21

Incyte Corp

INCY

-0.40%

101.32

Aptevo Therapeutics Inc

APVO

-4.58%

6.66

Biospecifics

BSTC

+0.15%

88.53